levothyroxine T4
Selected indexed studies
- Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption. (Front Endocrinol (Lausanne), 2022) [PMID:36561558]
- Hypothyroidism and metabolic cardiovascular disease. (Front Endocrinol (Lausanne), 2024) [PMID:38887272]
- Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review. (Clin Ther, 2017) [PMID:28153426]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Editorial: Levothyroxine Therapy in Patients With Hypothyroidism. (2021) pubmed
- L-T4 Therapy in Enteric Malabsorptive Disorders. (2021) pubmed
- Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption. (2022) pubmed
- Hypothyroidism and metabolic cardiovascular disease. (2024) pubmed
- Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review. (2017) pubmed
- Acquired Hypothyroidism in Children. (2023) pubmed
- Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose. (2024) pubmed
- Effects of levothyroxine in subclinical hypothyroidism and heart failure with reduced ejection fraction: An open-label randomized trial. (2024) pubmed
- Interference or Noninterference Between Soy and Levothyroxine: That Is the Question. A Narrative Review of Literature. (2023) pubmed
- [Central hypothyroidism]. (2019) pubmed